Xencor Stock (NASDAQ: XNCR) stock price, news, charts, stock research, profile.
Open | $24.110 |
Close | - |
Volume / Avg. | 650.170K / 714.789K |
Day Range | 22.270 - 24.110 |
52 Wk Range | 16.490 - 28.960 |
Market Cap | $1.380B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 0 |
Short Interest | 17.36% |
Days to Cover | 12.71 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Xencor (NASDAQ: XNCR) through any online brokerage.
Other companies in Xencor’s space includes: Gyre Therapeutics (NASDAQ:GYRE), 4D Molecular Therapeutics (NASDAQ:FDMT), Day One Biopharmaceutical (NASDAQ:DAWN), Protagonist Therapeutics (NASDAQ:PTGX) and Kiniksa Pharmaceuticals (NASDAQ:KNSA).
The latest price target for Xencor (NASDAQ: XNCR) was reported by BTIG on Tuesday, April 16, 2024. The analyst firm set a price target for 38.00 expecting XNCR to rise to within 12 months (a possible 69.72% upside). 12 analyst firms have reported ratings in the last year.
The stock price for Xencor (NASDAQ: XNCR) is $22.39 last updated Today at May 2, 2024 at 12:33 PM EDT.
There are no upcoming dividends for Xencor.
Xencor’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for Xencor.
Xencor is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.